Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03779971
Other study ID # HS66-Lentil/Chickpea Study
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date November 6, 2019
Est. completion date March 23, 2020

Study information

Verified date March 2020
Source USDA Beltsville Human Nutrition Research Center
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study is being conducted to determine the digestibility of and available energy from pulses.


Description:

Previous studies have demonstrated that the metabolizable energy (energy available to the body) from tree nuts is less than predicted by the Atwater factors (the standard approach to determining calorie value of a food). The Atwater approach is over 100 years old and is inaccurate for some foods. This study will be conducted to determine the metabolizable energy from two pulses, lentils and chickpeas. The study will be a human nutrition intervention involving consumption of a controlled diet followed by collection of urine and feces.


Recruitment information / eligibility

Status Completed
Enrollment 18
Est. completion date March 23, 2020
Est. primary completion date March 23, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 25 Years to 75 Years
Eligibility Inclusion Criteria:

- BMI between 19 and 38 kg/m2

- Age 25 to 75 years during intervention

Exclusion Criteria:

- Known (self-reported) allergy or adverse reaction to study foods

- Women who have given birth during the previous 12 months or who are pregnant/lactating or who plan to become pregnant during the study

- History of bariatric surgery or nutrient malabsorption disease (such as celiac disease), Crohn's disease, diabetes, or metabolic disorders that may interfere with the study

- History of certain cancer diagnosis or treatment in the last 3 years

- Smoking or use of tobacco products in the past 6 months

- Suspected or known strictures, fistulas or physiological/mechanical GI obstruction

- Use of certain medications or supplements (prescription or over-the-counter) that may interfere with the study objectives, including blood thinning medications

- Unable or unwilling to give informed consent or communicate with study staff

- Self-report of alcohol or substance abuse within the past 12 months and/or current treatment for these problems (long-term participation in Alcoholics Anonymous is not an exclusion)

- Other medical, psychiatric, or behavioral factors that in the judgment of the Principal Investigator may interfere with study participation or the ability to follow the intervention protocol

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Control Diet
Participants will consume a diet prepared and provided by the USDA Nutrition Center. The diet will contain no pulses, legumes, or beans.
Lentil Containing Diet
Participants will consume a diet prepared and provided by the USDA Nutrition Center. The diet will contain lentils.
Chickpea Containing Diet
Participants will consume a diet prepared and provided by the USDA Nutrition Center. The diet will contain chickpeas.

Locations

Country Name City State
United States USDA Beltsville Human Nutrition Research Center Beltsville Maryland

Sponsors (1)

Lead Sponsor Collaborator
USDA Beltsville Human Nutrition Research Center

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Energy excreted in feces and urine Energy (units of calories) excreted in feces and urine will be determined by bomb calorimetry. Cumulative from day 10-17
Primary Energy excreted in feces and urine Energy (units of calories) excreted in feces and urine will be determined by bomb calorimetry. Cumulative from day 39-46
Primary Energy excreted in feces and urine Energy (units of calories) excreted in feces and urine will be determined by bomb calorimetry. Cumulative from day 57-64
Secondary Nitrogen excreted in feces and urine Nitrogen (g) excreted in feces and urine will be measured. Cumulative from day 10-17, day 39-46, day 57-64
Secondary Fat excreted in feces Fat (g) excreted in feces will be measured. Cumulative from day 10-17, day 39-46, day 57-64
See also
  Status Clinical Trial Phase
Active, not recruiting NCT04677920 - The Healthy Cookie Energy Study: Understanding How Healthy Cookies Affect Mitochondrial Biology N/A
Active, not recruiting NCT03312920 - Investigating Memory Retrieval Improvement in Healthy Subjects N/A
Completed NCT03309072 - Investigating Accelerated Learning and Memory in Healthy Subjects Using a Face Name Memory Task N/A
Completed NCT03289832 - Effect of Orally Delivered Phytochemicals on Aging and Inflammation in the Skin N/A
Enrolling by invitation NCT06133530 - Human Milk Oligosaccharides (HMOs) and Gut Microbiota, Immune System in Antarctica N/A
Completed NCT05141903 - Dietary Supplement With and Without a Probiotic and/or Antibiotic
Completed NCT01689259 - Comparative Pharmacokinetics and Safety of TNX-102 SL Tablets and Cyclobenzaprine Oral Tablet in Healthy Adults Phase 1
Completed NCT01187875 - Resistant Starch and Satiety Phase 0
Completed NCT03312699 - Effects of Aging on Primary and Secondary Vaccine Responses in a 15-Year Longitudinal Cohort Phase 1
Completed NCT03319134 - Investigating the Neural Correlates in Memory Retrieval After HD-tDCS N/A
Recruiting NCT04104360 - Galacto-oligosaccharides and Intestinal Activity N/A
Completed NCT03228693 - Gene Expression and Biomarker Profiling of Keloid Skin N/A
Completed NCT04206293 - A Study to Evaluate The Impact on Skin Quality Attributes by Juvederm® Volite Injection on Healthy Volunteers N/A
Completed NCT04146532 - Aspirin Effects on Emotional Reactions Early Phase 1
Recruiting NCT06011018 - Comparison of Effects of Mirror Therapy Combined With Neuromuscular Electrical Stimulation or Binaural Beats Stimulation on Cortical Excitability, Heart Rate Variability and Lower Limb Motor Function in Patients With Stroke N/A
Completed NCT05093205 - STUDY TO EVALUATE THE EFFECT OF PF-06882961 ON SINGLE DOSE ATORVASTATIN, MEDAZOLAM AND ORALCONTRACEPTIVE PHARMACOKINETICS IN HEALTHY ADULT PARTICIPANTS Phase 1
Completed NCT04596709 - Investigation of Blood Glucose and Insulin Response After Intake of Vitalose N/A
Completed NCT04272450 - Respiratory Muscle Strength in Different Age Groups
Completed NCT02044679 - Evaluation of Spot Urine as a Biomarker of Fluid Intake in Real Life Conditions N/A
Completed NCT01402973 - Pilot Study of a Dietary Intervention Based Upon Advanced Glycation End Products N/A